Literature DB >> 9671947

Identification, distribution, and tissular origin of the alpha5(IV) and alpha6(IV) collagen chains in the developing human intestine.

A Simoneau1, F E Herring-Gillam, P H Vachon, N Perreault, N Basora, Y Bouatrouss, L P Pageot, J Zhou, J F Beaulieu.   

Abstract

The basement membrane type IV collagen is a family composed of six genetically distinct but structurally similar polypeptide chains, alpha1-alpha6. The alpha1(IV) and alpha2(IV) chains are ubiquitous components of all BMs whereas the other four have a restricted tissue distribution. In the present study, we have analyzed the expression, distribution, and cellular origin of the alpha5(IV) and alpha6(IV) chains in the developing and adult human small intestine and in well-characterized in vitro models by indirect immunofluorescence, Western blot, and RT-PCR. We have found that in the fetal small intestine, alpha(IV) and alpha6(IV) are present in the epithelial BM and, in contrast to alpha1(IV) and alpha2(IV), are produced by both epithelial and mesenchymal cells. A distinct tissular origin for the alpha1/alpha2(IV) and alpha5/alpha6(IV) chains suggests that alpha5(IV) and alpha6(IV) associate as a heterotrimer in this organ. We have also found that a particular situation of alpha5(IV)/alpha6(IV) chain expression occurs in the adult intestine. Indeed, as compared with the fetal intestine, alpha6(IV) chain production is maintained while the expression of the alpha5(IV) chain is substantially reduced. Altered expression of the alpha5(IV) chain was also observed in the differentiating enterocytic-like Caco-2/15 cells, suggesting that in the intestinal model, the alpha5(IV) chain is subject to a regulated expression. Taken together, these observations indicate that the human intestinal epithelial BM contains up to four type IV collagen chains: the classical alpha1(IV)/alpha2(IV) chains, which originate from mesenchymal cells, and the alpha5(IV)/alpha6(IV) chains, which are of both epithelial and mesenchymal origin and have their expression regulated throughout development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671947     DOI: 10.1002/(SICI)1097-0177(199807)212:3<437::AID-AJA11>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  7 in total

1.  RhoA-dependent switch between alpha2beta1 and alpha3beta1 integrins is induced by laminin-5 during early stage of HT-29 cell differentiation.

Authors:  S P Gout; M R Jacquier-Sarlin; L Rouard-Talbot; P Rousselle; M R Block
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

2.  Differential expression of basement membrane type IV collagen alpha chains in gastric intramucosal neoplastic lesions.

Authors:  Yoshifumi Baba; Ken-Ichi Iyama; Koei Ikeda; Shinji Ishikawa; Naoko Hayashi; Nobutomo Miyanari; Yumi Honda; Yoshikazu Sado; Yoshifumi Ninomiya; Hideo Baba
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

3.  Integrin α6β4 in colorectal cancer.

Authors:  Jean-François Beaulieu
Journal:  World J Gastrointest Pathophysiol       Date:  2010-04-15

Review 4.  The extracellular matrix of the gastrointestinal tract: a regenerative medicine platform.

Authors:  George S Hussey; Timothy J Keane; Stephen F Badylak
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-07-12       Impact factor: 46.802

5.  Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region.

Authors:  Koei Ikeda; Ken-ichi Iyama; Nobuyuki Ishikawa; Hiroshi Egami; Mitsuyoshi Nakao; Yoshikazu Sado; Yoshifumi Ninomiya; Hideo Baba
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

6.  Collagen mRNA levels changes during colorectal cancer carcinogenesis.

Authors:  Hanne Skovbjerg; Dorit Anthonsen; Inger M B Lothe; Kjell M Tveit; Elin H Kure; Lotte K Vogel
Journal:  BMC Cancer       Date:  2009-05-07       Impact factor: 4.430

7.  Sphingosine-1-phosphate stimulates human Caco-2 intestinal epithelial proliferation via p38 activation and activates ERK by an independent mechanism.

Authors:  Vijayalakshmi Thamilselvan; Wei Li; Bauer E Sumpio; Marc D Basson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-04       Impact factor: 2.416

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.